Mengyang Di, MD, PhD
Fred Hutch/University of Washington Cancer Consortium
4
4
0
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+16 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Joseph M Tuscano
University of California, Davis
Shared therapeutic areas:
Ryan Lynch
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Ajay Gopal
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Jordan Gauthier
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Yago L Nieto
M.D. Anderson Cancer Center
Shared therapeutic areas:
Alex F Herrera
City of Hope Medical Center
Shared therapeutic areas:
Tanya Siddiqi
City of Hope Medical Center
Shared therapeutic areas:
Rachel B. Salit
Fred Hutch/University of Washington Cancer Consortium
Shared therapeutic areas:
Worked with same sponsors:
Elias Jabbour, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Mark J Roschewski, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
All 4 trials loaded